- Home
- BMRN vs IEX Comparison
BMRN vs IEX Comparison
Compare BMRN & IEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- IEX
- Stock Information
- Founded
- BMRN 1996
- IEX 1987
- Country
- BMRN United States
- IEX United States
- Employees
- BMRN N/A
- IEX N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- IEX Fluid Controls
- Sector
- BMRN Health Care
- IEX Industrials
- Exchange
- BMRN Nasdaq
- IEX Nasdaq
- Market Cap
- BMRN 11.3B
- IEX 13.6B
- IPO Year
- BMRN 1999
- IEX 1991
- Fundamental
- Price
- BMRN $57.54
- IEX $164.85
- Analyst Decision
- BMRN Buy
- IEX Buy
- Analyst Count
- BMRN 23
- IEX 8
- Target Price
- BMRN $93.14
- IEX $211.86
- AVG Volume (30 Days)
- BMRN 2.5M
- IEX 863.1K
- Earning Date
- BMRN 08-04-2025
- IEX 07-30-2025
- Dividend Yield
- BMRN N/A
- IEX 1.72%
- EPS Growth
- BMRN 154.69
- IEX N/A
- EPS
- BMRN 3.40
- IEX 6.18
- Revenue
- BMRN $3,063,608,000.00
- IEX $3,340,800,000.00
- Revenue This Year
- BMRN $12.34
- IEX $5.97
- Revenue Next Year
- BMRN $10.01
- IEX $4.04
- P/E Ratio
- BMRN $16.93
- IEX $26.66
- Revenue Growth
- BMRN 18.36
- IEX 4.73
- 52 Week Low
- BMRN $52.93
- IEX $153.36
- 52 Week High
- BMRN $94.85
- IEX $238.22
- Technical
- Relative Strength Index (RSI)
- BMRN 47.03
- IEX 43.10
- Support Level
- BMRN $56.45
- IEX $157.25
- Resistance Level
- BMRN $58.62
- IEX $169.80
- Average True Range (ATR)
- BMRN 1.95
- IEX 4.48
- MACD
- BMRN -0.25
- IEX 0.30
- Stochastic Oscillator
- BMRN 15.51
- IEX 26.17
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About IEX IDEX Corporation
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.